Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,070 total articles
CoreWeave sits at the nexus of GPU-driven AI demand and hyperscaler data-center spending. Recent multi-year deals with Meta and Anthropic, an enlarged $21B Meta expansion, and price increases give the company a clear runway for revenue and margin improvement. Valuation is rich for a loss-making operator, but for patient, risk-tolerant investors thi…
Snowflake (SNOW) is trading well below its 52-week highs after a sectorwide software selloff and fresh legal headlines. Fundamentals still support long-term demand for a modern data cloud, but valuation and momentum favor option sellers today. My trade: sell cash-secured puts in the mid-term (45 trading days) to collect premium and be paid to own t…
Bloom Energy rallied into a breakout after reports of a commercial agreement with Oracle that validates its positioning as a data-center power provider. The company shows rising revenue momentum and improving cash flow, but valuation remains rich (market cap ~$56.3B) and leverage is high. This trade idea is a tactical long with a clear entry at $20…
Rocket Lab's recent weakness looks like an overreaction. With a growing space-systems services business, steady small-sat launch demand and an upcoming Neutron program cadence that can re-rate sentiment, the current pullback offers a mid-term buying opportunity. Trade plan: enter $7.50, stop $5.75, target $12.00 with a 45-trading-day horizon.
Amazon looks set for a fresh re-rating if three new, concrete catalysts play out: a strategic shift in 2026 data-center spending, accelerating rollout of Amazon-designed AI silicon in AWS, and faster e-commerce automation that cuts fulfillment costs. Valuation at roughly $2.57T and a P/E ~33 already prices growth; this idea is a directional swing t…
Blue Owl (OWL) has been punished on private credit redemption headlines, but the firm's fee mix, strong free cash flow and a 52-week range that still leaves considerable upside argue for a tactical long. This trade idea outlines an entry, stop and target for a long-term recovery play and the key catalysts that would validate the thesis.
Patterson-UTI is positioned to benefit from a renewed run of U.S. and international drilling activity. With a market cap near $4.0B, attractive cash flow (FCF $372M), modest leverage, and a dividend yield north of 3%, PTEN offers a favorable risk/reward into what looks like the next drilling cycle leg up. Trade plan: enter $10.56, stop $8.75, targe…
Elbit Systems ($ESLT) is riding a clear war premium: a $28.1B backlog, fresh multi-hundred-million dollar contracts and accelerating ISTAR/EW revenue are boosting sentiment. But a $43.5B market cap, rich 82x PE and likely capacity limits on ramping production make this a tactical trade rather than a buy-and-forget idea. Enter on a modest pullback, …
Vistance Networks is no longer a balance-sheet cleanup story. After the divestiture of its Connectivity and Cable Solutions business and a planned $10+ per-share special distribution, the company emerges with retired debt, a cleaner portfolio of higher-growth networking and access solutions, and a valuation that appears undemanding. Technical momen…
Oneok (OKE) yields roughly 4.9% and benefits from higher energy prices tied to the Iran crisis, but 2026 guidance points to a growth pause while leverage is elevated and free cash flow is already largely committed to the dividend and projects. This trade idea takes a measured short stance over a mid-term horizon to capture mean reversion if fundame…
LVMUY has pulled back into what looks like a durable value zone after a sharp correction from its January highs. The business is diversified across resilient luxury categories, trades at a mid-20s P/E with a $273.7B market cap, and shows early technical signs of stabilized momentum. This trade plan targets a recovery toward the $130s over the next …
Spyre Therapeutics reported strong Part A induction results for SPY001 in ulcerative colitis (9.2-point Robarts histology improvement; 40% clinical remission; 51% endoscopic improvement), and is now enrolling Part B. The stock pulled back after a $300M common-share offering was announced, creating a tradeable setup. We favor a mid-term long (45 tra…
Commvault (CVLT) looks actionable on takeover speculation and supportive analyst momentum. Fundamentals show healthy cash flow and outsized ROE, while the float is compact and short interest remains meaningful. We upgrade to a Buy for a mid-term swing trade and lay out entry, stop and target.
Cisco (CSCO) is exposed to accelerating AI and optical networking demand from hyperscalers and large enterprises. Strong free cash flow, a healthy balance sheet and improving technicals support a long directional trade. Entry $82.34, stop $76.00, target $95.00 over a 180 trading day horizon.
Euroseas (ESEA) trades at a deep P/E and modest PB despite rising charter rates, a growing yield and improving technicals. With a tight float, active short interest and recent time-charters on fuel-efficient feeders, this is a tactical long for patient investors willing to hold through shipping seasonality.
Intel's recent rally and newfound role as a major AI supply partner have the stock trading like a structural-growth story. With a market cap near $327B, improved technicals, and key catalysts ahead, there's a high-risk, high-reward trade to capture a potential re-rating similar to what Micron experienced. This idea lays out entry, stop, targets, ho…
SentinelOne is trading at a materially cheaper multiple than a year ago while still showing healthy revenue growth and positive free cash flow. With enterprise demand for AI-aware endpoint security picking up after recent high-profile AI threat stories, the downside is limited relative to upside from multiple expansion and margin inflection. This t…
FUCHS SE (FUPEF) has shown virtually no breakout after years of sideways performance while recent momentum metrics have become extreme. Elevated short interest and near-zero average daily volume create a dangerous cocktail for both longs and shorts, but the technical picture and mean-reversion logic argue for a disciplined short trade over the next…
Fortinet's pullback has left the stock trading near multi-month lows while core fundamentals remain intact: solid free cash flow ($2.226B trailing), healthy ROA/ROE, and a direct line into mandated enterprise spending from post-quantum cryptography upgrades. Valuation looks full on headline multiples but the risk-reward for a mid-term long is attra…
Redwire (RDW) is a modular space-infrastructure supplier that just landed a string of high-profile contracts and is showing early signs of margin expansion. Market cap sits near $1.9B and the stock is trading above its short-term moving averages, but the company remains unprofitable and free cash flow is negative. This idea lays out a mid-term swin…
Harrow (HROW) recently saw heightened headline activity - a small 8.625% note sale and a large block sale by a 10% holder - that appears to have pushed sentiment too far. Fundamentals (reaffirmed 2025 revenue guidance of $270-280M, positive free cash flow ~$43M) and technicals (price above the 10/20-day SMAs; heavy short interest that could fuel co…
Duolingo has rebuilt the plumbing that converts engagement into durable revenue. With 52.7M daily active users, record $1.04B revenue and $414M net profit in 2025, the market is pricing in a long slog of weak monetization. We think that's too pessimistic. Behavioral design, new premium AI tiers and stronger ARPU mechanics create a clear path to hig…
Western Midstream (WES) offers an 8.9% yield, steady free cash flow of roughly $1.5B, and valuation metrics that leave room for a modest re-rate. This trade targets capital appreciation plus income over a 180-trading-day horizon with a controlled stop to protect against distribution or commodity-driven shocks.
Tarsus is translating FDA approval into cash flow. Net product sales surged to $451.4M in 2025 with gross margins near 93%, and the stock sits above key moving averages with bullish momentum. This is a tactical long for investors willing to back continued commercial execution and pipeline progress over the next 45 trading days.
Austal (AUTLF) remains a Strong Buy. The stock is technically digesting recent selling while momentum signals are turning constructive and short activity is elevated — a setup that can produce outsized rebounds. Our trade plan targets a near-term rally to $4.25 from an entry at $3.27, with a strict stop at $2.90. Free cash flow volatility and execu…
